FDA Drug Recalls

Recalls / Class III

Class IIID-0005-2023

Product

Esomeprazole Magnesium Delayed-Release Capsules, USP, 40mg, Rx Only, 90 Capsules per bottle, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-735-90.

Brand name
Esomeprazole Magnesium
Generic name
Esomeprazole Magnesium
Active ingredient
Esomeprazole Magnesium
Route
Oral
NDCs
63304-734, 63304-735
FDA application
ANDA209735
Affected lot / code info
Lot AC14304, Exp 12/2022.

Why it was recalled

Superpotent Drug: Out of specification for assay at the 12-month timepoint.

Recalling firm

Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Manufacturer
Sun Pharmaceutical Industries, Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2 Independence Way, N/A, Princeton, New Jersey 08540-6620

Distribution

Quantity
8640 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2022-06-21
FDA classified
2022-10-06
Posted by FDA
2022-10-05
Terminated
2023-08-11
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0005-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Esomeprazole Magnesium · FDA Drug Recalls